This protocol is judged by an institutional critique board, an unbiased team that assessments any clinical trials involving humans. If a research will involve a Program I drug, as soon as the board approves the protocol as ethical, the researchers should apply for an investigational new drug (IND) amount from the FDA.He stated he appreciated worki